Analysis of predictive and prognostic soluble biomarkers in advanced non-small cell lung cancer (NSCLC) patients treated with anti-PD1/PDL1

被引：0
|
作者：
Gallach Garcia, S. [1 ]
Garde Noguera, J. [2 ]
Torres Martinez, S. [1 ]
Aparisi Aparisi, F. D. A. [3 ]
Vidal Martinez, J. [4 ]
Escorihuela, E. [5 ]
Gisbert Criado, R. [4 ]
Moreno, A. [5 ]
Ferrero Gimeno, M. [5 ]
Meri Abad, M. [3 ]
Shaheen, I. [3 ]
Calabuig-Farinas, S. [6 ]
Blasco Cordellat, A. [7 ]
Honrubia Peris, B. [2 ]
Garcia Sanchez, J. [2 ]
Jantus Lewintre, E. [8 ]
Camps, C. [9 ]
机构：
[1] FIHGUV Fdn Invest Hosp Gen Univ Valencia, Unidad Mixta TRIAL CIPF FIHGUV, CIBERONC, Mol Oncol Lab, Valencia, Spain
[2] Hosp Arnau Vilanova, Med Oncol, Valencia, Spain
[3] Hosp Gen Univ Valencia, Med Oncol, Valencia, Spain
[4] Hosp Arnau Vilanova, Dept Clin Anal, Valencia, Spain
[5] FIHGUV Fdn Invest Hosp Gen Univ Valencia, Unidad Mixta TRIAL CIPF FIHGUV, Mol Oncol Lab, Valencia, Spain
[6] Univ Valencia, FIHGUV Fdn Invest Hosp Gen Univ Valencia, Unidad Mixta TRIAL CIPF FIHGUV, Dept Pathol,Mol Oncol, Valencia, Spain
[7] Hosp Gen Univ Valencia, CIBER ONC, Med Oncol, Valencia, Spain
[8] Univ Politecn Valencia, FIHGUV Fdn Invest Hosp Gen Univ Valencia, Unidad Mixta TRIAL CIPF FIHGUV, Dept Biotechnol,CIBERONC,Mol Oncol, Valencia, Spain
[9] Univ Valencia, Fdn Invest Hosp Gen Univ Valencia, Unidad Mixta TRIAL CIPF FIHGUV, Med Oncol,Hosp Gen Univ Valencia,CIBERONC,Dept Me, Valencia, Spain
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1159
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1039P
引用
收藏
页码：S714 / S714
页数：1
相关论文
共 50 条
  • [41] New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab
    Bylicki, Olivier
    Paleiron, Nicolas
    Rousseau-Bussac, Gaelle
    Chouaid, Christos
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 4051 - 4064
  • [42] Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy
    Qiaoyun Tan
    Liyuan Dai
    Yanrong Wang
    Shuxia Liu
    Te Liang
    Rongrong Luo
    Shasha Wang
    Ning Lou
    Haizhu Chen
    Yu Zhou
    Qiaofeng Zhong
    Jianliang Yang
    Puyuan Xing
    Xingsheng Hu
    Yutao Liu
    Shengyu Zhou
    Jiarui Yao
    Di Wu
    Zhishang Zhang
    Le Tang
    Xiaobo Yu
    Xiaohong Han
    Yuankai Shi
    [J]. Cancer Immunology, Immunotherapy, 2022, 71 : 1681 - 1691
  • [43] Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies
    Soyano, Aixa E.
    Dholaria, Bhagirathbhai
    Marin-Acevedo, Julian A.
    Diehl, Nancy
    Hodge, David
    Luo, Yan
    Manochakian, Rami
    Chumsri, Saranya
    Adjei, Alex
    Knutson, Keith L.
    Lou, Yanyan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [44] Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo).
    Costantini, Adrien
    Julie, Catherine
    Dumenil, Coraline
    Helias-Rodzewicz, Zofia
    Dumoulin, Jennifer
    Giraud, Violaine
    Labrune, Sylvie
    Chinet, Thierry
    Emile, Jean-Francois
    Giroux-Leprieur, Etienne
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [45] Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy
    Tan, Qiaoyun
    Dai, Liyuan
    Wang, Yanrong
    Liu, Shuxia
    Liang, Te
    Luo, Rongrong
    Wang, Shasha
    Lou, Ning
    Chen, Haizhu
    Zhou, Yu
    Zhong, Qiaofeng
    Yang, Jianliang
    Xing, Puyuan
    Hu, Xingsheng
    Liu, Yutao
    Zhou, Shengyu
    Yao, Jiarui
    Wu, Di
    Zhang, Zhishang
    Tang, Le
    Yu, Xiaobo
    Han, Xiaohong
    Shi, Yuankai
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (07) : 1681 - 1691
  • [46] PDL1 EXPRESSION IN METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS FROM COLOMBIA (CLICAP)
    Rojas, Leonardo
    Cardona Cardona, Andres Felipe
    Arrieta, Oscar
    Carranza, Hernan
    Martin, Claudio
    Otero, Jorge
    Lema, Mauricio
    Cuello, Mauricio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S199 - S200
  • [47] Profiling of Tumor Mutational Burden and PD1/PDL1 Immunohistochemistry (INC) in Non-Small Cell Lung Cancer
    Elvin, Julia A.
    Goldberg, Michael E.
    Gay, Laurie M.
    Suh, James
    Vergilio, Jo-Anne
    Ramkissoon, Shakti H.
    Ali, Siraj M.
    Schrock, Alexa
    Fabrizio, David
    Frampton, Garrett
    Miller, Vincent
    Stephens, Philip
    Ross, Jeffrey
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 477A - 477A
  • [48] PDL1 Expression in Metastatic Non-Small Cell Lung Cancer Patients from Colombia (CLICaP)
    Cardona, Andres F.
    Rojas, Leonardo
    Vargas, Carlos A.
    Carranza, Hernan
    Otero, Jorge M.
    Arrieta Rodriguez, Oscar
    Martin, Claudio
    Corrales, Luis
    Cuello, Mauricio
    Rosell, Rafael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S602 - S602
  • [49] Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
    Sgambato, Assunta
    Casaluce, Francesca
    Sacco, Paola C.
    Palazzolo, Giovanni
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    [J]. CURRENT DRUG SAFETY, 2016, 11 (01) : 62 - 68
  • [50] Non-Invasive Detection of Predictive Biomarkers for PD-1 Inhibitor Treated Non-Small Cell Lung Cancer Patients
    Stensgaard, S.
    Thomsen, A.
    Dissing, J. G.
    Knudsen, S. H.
    Meldgaard, P.
    Sorensen, B. S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S381 - S381
12345